1. Home
  2. KNSA vs AGM Comparison

KNSA vs AGM Comparison

Compare KNSA & AGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • AGM
  • Stock Information
  • Founded
  • KNSA 2015
  • AGM 1987
  • Country
  • KNSA United Kingdom
  • AGM United States
  • Employees
  • KNSA N/A
  • AGM N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • AGM Finance Companies
  • Sector
  • KNSA Health Care
  • AGM Finance
  • Exchange
  • KNSA Nasdaq
  • AGM Nasdaq
  • Market Cap
  • KNSA 2.6B
  • AGM 2.3B
  • IPO Year
  • KNSA 2018
  • AGM N/A
  • Fundamental
  • Price
  • KNSA $35.92
  • AGM $188.17
  • Analyst Decision
  • KNSA Strong Buy
  • AGM Hold
  • Analyst Count
  • KNSA 6
  • AGM 1
  • Target Price
  • KNSA $40.83
  • AGM $217.00
  • AVG Volume (30 Days)
  • KNSA 392.6K
  • AGM 69.4K
  • Earning Date
  • KNSA 10-28-2025
  • AGM 11-03-2025
  • Dividend Yield
  • KNSA N/A
  • AGM 3.20%
  • EPS Growth
  • KNSA N/A
  • AGM 3.61
  • EPS
  • KNSA 0.07
  • AGM 16.97
  • Revenue
  • KNSA $529,332,000.00
  • AGM $368,431,000.00
  • Revenue This Year
  • KNSA $37.21
  • AGM $12.46
  • Revenue Next Year
  • KNSA $11.99
  • AGM $8.69
  • P/E Ratio
  • KNSA $542.28
  • AGM $11.04
  • Revenue Growth
  • KNSA 56.18
  • AGM 2.95
  • 52 Week Low
  • KNSA $17.82
  • AGM $159.64
  • 52 Week High
  • KNSA $37.34
  • AGM $217.14
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 60.14
  • AGM 39.62
  • Support Level
  • KNSA $35.29
  • AGM $195.00
  • Resistance Level
  • KNSA $37.34
  • AGM $209.18
  • Average True Range (ATR)
  • KNSA 1.00
  • AGM 4.11
  • MACD
  • KNSA -0.15
  • AGM -2.77
  • Stochastic Oscillator
  • KNSA 65.30
  • AGM 14.56

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About AGM Federal Agricultural Mortgage Corporation

Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.

Share on Social Networks: